Life threatening haemoptysis in cystic fibrosis: an alternative therapeutic approach.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2281432.
- Also identified by PMC identifier 462850.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Desmopressin and vasopressin were used to control massive haemoptysis in a patient with cystic fibrosis. After bolus doses a continuous infusion of vasopressin was maintained for 36 hours and haemoptysis stopped.
Medical subject headings
- Cystic Fibrosis
- Deamino Arginine Vasopressin
- Hemoptysis
- Vasopressins